Table 2:
Incidence rate and risk of renal cancer according to the presence of CKD and gout.
| Groups | Renal cancer events/total | Incidence rate/1000 person-years | Model 1 | Model 2 | Model 3 | Model 1 | Model 2 | Model 3 |
|---|---|---|---|---|---|---|---|---|
| CKD−Gout− | 1943/741 839 | 0.29 | 1 (ref.) | 1 (ref.) | 1 (ref.) | 1 (ref.) | 1 (ref.) | 1 (ref.) |
| CKD−Gout+ | 91/21 164 | 0.48 | 1.67 (1.35, 2.05) | 1.30 (1.05, 1.60) | 1.28 (1.04, 1.58) | 1.67 (1.35, 2.05) | 1.30 (1.05, 1.60) | 1.28 (1.04, 1.58) |
| CKD+Gout− | 291/79 206 | 0.44 | 1.52 (1.35, 1.72) | 1.21 (1.06, 1.37) | 1.20 (1.06, 1.37) | 1 (ref.) | 1 (ref.) | 1 (ref.) |
| CKD+Gout+ | 51/5675 | 1.14 | 3.97 (3.00, 5.23) | 2.39 (1.81, 3.17) | 2.35 (1.77, 3.11) | 2.60 (1.93, 3.51) | 1.98 (1.47, 2.67) | 1.95 (1.45, 2.63) |
| P for interaction | 0.016 | 0.022 | 0.024 |
Model 1: unadjusted; model 2: adjusted for age, sex, income, hypertension, dyslipidaemia, smoking, drinking, regular exercise and BMI; model 3: adjusted for the variables in model 2 plus diabetes duration, insulin, OHA and glucose.